Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 5 buys in history.
Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Xeris Biopharma Holdings, Inc. | 3,788,064 | reported | 31 Jan 2024 | tx 17+5,757,633 |
| PROTEIN DESIGN LABS INC/DE | 214,563 | reported | 08 Jun 2018 | tx 4+214,563 |
| Vistagen Therapeutics, Inc. | 35,200 | reported | 27 Oct 2025 | tx 1+35,200 |
| Iterum Therapeutics plc | 31,390 | reported | 24 May 2019 | tx 10+34,362−27,708 |
| Neos Therapeutics, Inc. | 18,322 | reported | 03 Jul 2017 | tx 2+33,099 |
| Milestone Pharmaceuticals Inc. | 15,000 | reported | 05 Jun 2020 | tx 1+15,000 |
| NEWLINK GENETICS CORP | 13,309 | reported | 12 May 2017 | tx 14+113,560 |
| XERIS PHARMACEUTICALS INC | 0 | reported | 05 Oct 2021 | tx 21+1,259,365−2,091,356 |
| Sucampo Pharmaceuticals, Inc. | 0 | reported | 13 Feb 2018 | tx 7+44,960−24,930 |
| Durata Therapeutics, Inc. | 0 | reported | 17 Nov 2014 | tx 17+490,903−1,314,208 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 27 Oct 2025 | GRANT_AWARD | Vistagen Therapeutics, Inc. | 35,200 | — | deriv |
| 31 Jan 2024 | GRANT_AWARD | Xeris Biopharma Holdings, Inc. | 1,500,000 | 0.00 USD | |
| 31 Jan 2024 | GRANT_AWARD | Xeris Biopharma Holdings, Inc. | 500,000 | 0.00 USD | deriv |
| 09 Aug 2023 | PURCHASE | Xeris Biopharma Holdings, Inc. | 10,000 | 2.38 USD | |
| 31 Jan 2023 | GRANT_AWARD | Xeris Biopharma Holdings, Inc. | 750,000 | 0.00 USD | |
| 13 Dec 2022 | PURCHASE | Xeris Biopharma Holdings, Inc. | 20,000 | 1.45 USD | |
| 12 May 2022 | PURCHASE | Xeris Biopharma Holdings, Inc. | 100,000 | 1.40 USD | |
| 03 Jan 2022 | GRANT_AWARD | Xeris Biopharma Holdings, Inc. | 600,000 | 0.00 USD | |
| 15 Nov 2021 | PURCHASE | Xeris Biopharma Holdings, Inc. | 20,000 | 2.28 USD | |
| 11 Nov 2021 | PURCHASE | Xeris Biopharma Holdings, Inc. | 200,000 | 2.08 USD | |
| 05 Oct 2021 | OTHER | XERIS PHARMACEUTICALS INC | 410,833 | — | |
| 05 Oct 2021 | OTHER | XERIS PHARMACEUTICALS INC | 197,231 | — | |
| 05 Oct 2021 | OTHER | XERIS PHARMACEUTICALS INC | 13,430 | — | |
| 05 Oct 2021 | OTHER | XERIS PHARMACEUTICALS INC | 200,000 | — | deriv |
| 05 Oct 2021 | OTHER | XERIS PHARMACEUTICALS INC | 400,000 | — | deriv |
| 05 Oct 2021 | OTHER | XERIS PHARMACEUTICALS INC | 98,252 | — | deriv |
| 05 Oct 2021 | OTHER | XERIS PHARMACEUTICALS INC | 69,822 | — | deriv |
| 05 Oct 2021 | OTHER | XERIS PHARMACEUTICALS INC | 668,065 | — | deriv |
| 05 Oct 2021 | GRANT_AWARD | Xeris Biopharma Holdings, Inc. | 197,231 | — | |
| 05 Oct 2021 | GRANT_AWARD | Xeris Biopharma Holdings, Inc. | 13,430 | — | |
| 05 Oct 2021 | GRANT_AWARD | Xeris Biopharma Holdings, Inc. | 410,833 | — | |
| 05 Oct 2021 | GRANT_AWARD | Xeris Biopharma Holdings, Inc. | 668,065 | — | deriv |
| 05 Oct 2021 | GRANT_AWARD | Xeris Biopharma Holdings, Inc. | 69,822 | — | deriv |
| 05 Oct 2021 | GRANT_AWARD | Xeris Biopharma Holdings, Inc. | 400,000 | — | deriv |
| 05 Oct 2021 | GRANT_AWARD | Xeris Biopharma Holdings, Inc. | 200,000 | — | deriv |
2 purchases reported after at least 12 months of silence — most recent on 23 Aug 2018.